-
Hot Stocks: Peregrine Pharmaceuticals (NASDAQ:PPHM), King Digital Entertainment plc (NYSE:KING), Franklin Street Properties Corp. (NYSEMKT:FSP), WPX Energy (NYSE:WPX), Seaboard (NYSEMKT:SEB)
On Thursday shares of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) closed at $1.32. Company’s sales growth for last 5 years was 4.20%. Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) announced the presentation of three posters at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held May 29-June 2, 2015 in Chicago, Illinois. King Digital Entertainment plc…
-
Shining on Major News: Whiting Petroleum Corp. (NYSE:WLL), GrubHub Inc. (NYSE:GRUB), Monmouth Real Estate Investment (NYSE:MNR), Peregrine Pharmaceuticals (NASDAQ:PPHM), TetraLogic Pharmaceuticals (NASDAQ:TLOG)
On Wednesday shares of Whiting Petroleum Corp. (NYSE:WLL) closed at $36.76. Company’s sales growth for last 5 years was 26.90% and EPS growth for next 5 years is recorded as -8.04%. Whiting Petroleum Corp. (NYSE:WLL) posted a quarterly loss of $106.1 million, or $0.63 per share, versus a year-ago profit of $109.1 million, or $0.92…
-
Eye Catching Stocks: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Peregrine Pharmaceuticals (NASDAQ:PPHM), Boston Scientific Corporation (NYSE:BSX), Robert Half International Inc. (NYSE:RHI), Medivation (NASDAQ:MDVN)
On Monday shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) closed at $63.89. On 23 April, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced positive data from an investigator-sponsored study on triheptanoin, which is being developed for the treatment of movement disorders associated with glucose transporter type-1 deficiency syndrome (Glut1 DS). Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) in last trading activity moved…
-
Stocks in Focus: ArcelorMittal SA (ADR) (NYSE:MT), Peregrine Pharmaceuticals (NASDAQ:PPHM), Merck & Co. Inc. (NYSE:MRK), Stone Energy (NYSE:SGY), Sun Bancorp (NASDAQ:SNBC)
On Thursday shares of ArcelorMittal SA (ADR) (NYSE:MT) closed at $10.08. Company’s sales growth for last 5 years was 5.40%. ArcelorMittal SA (NYSE:MT) has received a “BB+” credit rating from analysts at Morningstar. The firm’s “BB+” rating suggests that the company is an above-average default risk. They also gave their stock a four star rating.…
-
Stock Highlights: Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM), Telecom Italia S.p.A. (NYSE:TI), Peregrine Pharmaceuticals (NASDAQ:PPHM), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
On Wednesday shares of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) closed at $23.20. Company’s EPS growth for next 5 years is recorded as 15.00%. Citigroup Inc. downgraded shares of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) from a buy rating to a neutral rating in a report issued on Thursday. On last trading day Telecom Italia…
-
Trader’s Recap: Altria Group Inc. (NYSE:MO), Peregrine Pharmaceuticals (NASDAQ:PPHM), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), One Liberty Properties Inc. (NYSE:OLP), Oneida Financial (NASDAQ:ONFC)
On Wednesday shares of Altria Group Inc. (NYSE:MO) closed at $51.62. Company’s sales growth for last 5 years was 0.80% and EPS growth for next 5 years is recorded as 8.10%. Altria Group Inc. (NYSE:MO) has received a “BBB” credit rating from Morningstar. The research firm’s “BBB” rating suggests that the company is a moderate…
-
Active Stocks: Peregrine Pharmaceuticals (NASDAQ:PPHM), EP Energy Corporation (NYSE:EPE), Biota Pharmaceuticals (NASDAQ:BOTA), Northwest Biotherapeutics (NASDAQ:NWBO), Ryland Group Inc. (NYSE:RYL)
On Tuesday shares of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) closed at $1.38. Company’s sales growth for last 5 years was 4.20%. Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) on March 31, 2015, declared the peer-reviewed publication of clinical data from a Phase I investigator-sponsored trial evaluating the company’s lead investigational immunotherapy bavituximab plus paclitaxel therapy in patients with HER2-negative…
-
Trending Stocks: Peregrine Pharmaceuticals (NASDAQ:PPHM), Celgene Corporation (NASDAQ:CELG), ACI Worldwide (NASDAQ:ACIW), Delek Logistics Partners, LP (NYSE:DKL), Intuitive Surgical (NASDAQ:ISRG)
On Tuesday shares of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) closed at $1.35. Company’s sales growth for last 5 years was 4.20%. Peregrine Pharmaceuticals (NASDAQ:PPHM) announced the peer-reviewed publication of clinical data from a Phase I investigator-sponsored trial evaluating the company’s lead investigational immunotherapy bavituximab plus paclitaxel therapy in patients with HER2-negative metastatic breast cancer. The manuscript…
-
5 Stocks Under Wall Street’s Radar: Peregrine Pharmaceuticals (NASDAQ:PPHM), PostRock Energy Corporation (NASDAQ:PSTR), Amicus Therapeutics (NASDAQ:FOLD), Google (NASDAQ:GOOGL), Hyatt Hotels (NYSE:H)
On Thursday shares of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) closed at $1.53. Company’s sales growth for last 5 years was 4.20%. Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) on March 12, 2015, released financial results for the third quarter of fiscal year (FY) 2015 ended January 31, 2015. The company also provided an update on its advancing clinical pipeline…
-
Investors Alert: National Bank of Greece (ADR) (NYSE:NBG), Peregrine Pharmaceuticals (NASDAQ:PPHM), The Sherwin-Williams Company (NYSE:SHW), Uroplasty (NASDAQ:UPI), GasLog (NYSE:GLOG)
National Bank of Greece (ADR) (NYSE:NBG), announced March 11, it expects the long delayed share tender of its Turkish unit to be completed in the next few weeks as the bank moves to shore up its capital base. The bank said some 7.15 billion new shares, and 800 million existing shares, in Finansbank AS will…